These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12445542)

  • 1. Uric acid concentrations and the mechanisms of cardiovascular disease.
    Waring WS; Maxwell SR; Webb DJ
    Eur Heart J; 2002 Dec; 23(23):1888-9. PubMed ID: 12445542
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylaxis and differential therapy of tumorlysis syndrome].
    Krych M; Dreyling M; Kneba M; Hoelzer D; Hiddemann W; Hallek M
    Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1440-5. PubMed ID: 15213877
    [No Abstract]   [Full Text] [Related]  

  • 3. Uric acid and cardiovascular risk.
    Hebert LA; Rovin B
    N Engl J Med; 2009 Jan; 360(5):540; author reply 540-1. PubMed ID: 19186313
    [No Abstract]   [Full Text] [Related]  

  • 4. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.
    Pui CH; Relling MV; Lascombes F; Harrison PL; Struxiano A; Mondesir JM; Ribeiro RC; Sandlund JT; Rivera GK; Evans WE; Mahmoud HH
    Leukemia; 1997 Nov; 11(11):1813-6. PubMed ID: 9369411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperuricemias in hematology using urate oxidase and allopurinol].
    Zittoun R; Dauchy F; Teillaud C; Barthélémy M; Bouchard P
    Ann Med Interne (Paris); 1976; 127(6-7):479-82. PubMed ID: 970811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology].
    Zittoun R; Dauchy F; Teillaud C; Barthelemy M; Bouchard P
    Nouv Presse Med; 1976 Jan; 5(2):91. PubMed ID: 772604
    [No Abstract]   [Full Text] [Related]  

  • 8. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006945. PubMed ID: 20556770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention.
    Gavin AR; Struthers AD
    Am J Cardiovasc Drugs; 2003; 3(5):309-14. PubMed ID: 14728064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary hyperuricemia in hematologic disease].
    Inai K; Tsutani H
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():299-303. PubMed ID: 12629735
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hyperuricemia with rasburicase review.
    de Bont JM; Pieters R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypouricaemic effect of polyethyleneglycol modified urate oxidase.
    Davis S; Park YK; Abuchowski A; Davis FF
    Lancet; 1981 Aug; 2(8241):281-3. PubMed ID: 6114326
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hyperuricemia in essential hypertension.
    Trachtman H
    Hypertension; 2007 Jun; 49(6):e45; author reply e46. PubMed ID: 17389252
    [No Abstract]   [Full Text] [Related]  

  • 14. Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia.
    Masera G; Jankovic M; Zurlo MG; Locasciulli A; Rossi MR; Uderzo C; Recchia M
    J Pediatr; 1982 Jan; 100(1):152-5. PubMed ID: 6948943
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Treatment of malignant haemopathies and urate oxidase.
    Kissel P; Mauuary G; Royer R; Toussain P
    Lancet; 1975 Jan; 1(7900):229. PubMed ID: 47468
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypo-uricemia].
    Bontoux D
    Rev Prat; 1989 Oct; 39(23):2079-82. PubMed ID: 2814280
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol as a therapeutic option in cardiovascular disease.
    Okafor ON; Farrington K; Gorog DA
    Pharmacol Ther; 2017 Apr; 172():139-150. PubMed ID: 27916655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of urate and xanthine oxidase inhibitors in cardiovascular disease.
    George J; Struthers AD
    Cardiovasc Ther; 2008; 26(1):59-64. PubMed ID: 18466421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of single-dose rasburicase in an obese female.
    Arnold TM; Reuter JP; Delman BS; Shanholtz CB
    Ann Pharmacother; 2004 Sep; 38(9):1428-31. PubMed ID: 15292497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.